Screening for vitamin d deficiency: A systematic review for the U.S. Preventive services task force

Annals of Internal Medicine

Volumn 162, Issue 2, 2015, Pages 109-122

  LeBlanc, Erin S ^a   Zakher, Bernadette ^b   Daeges, Monica ^b   Pappas, Miranda ^b   Chou, Roger ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D;

CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; FALL RISK; FRACTURE; HUMAN; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING; SYSTEMATIC REVIEW; UNITED STATES; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; ASYMPTOMATIC DISEASE; BLOOD; DIET SUPPLEMENTATION; FALLING; FRACTURES, BONE; HOME FOR THE AGED; INSTITUTIONALIZATION; MASS SCREENING; PREVENTION AND CONTROL; RISK ASSESSMENT; TREATMENT OUTCOME;

ACCIDENTAL FALLS; ASYMPTOMATIC DISEASES; CALCIUM; DIETARY SUPPLEMENTS; FRACTURES, BONE; HOMES FOR THE AGED; HUMANS; INSTITUTIONALIZATION; MASS SCREENING; MORTALITY; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84921646903     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-1659     Document Type: Review

References (124)

1. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807-20. [PMID: 19543765] doi:10.1007/s00198-009-0954-6 2.
2. Holvik K, Ahmed LA, Forsmo S, Gjesdal CG, Grimnes G, Samuelsen SO, et al. Low serum levels of 25-hydroxyvitamin D predict hip fracture in the elderly: A NOREPOS study. J Clin Endocrinol Metab. 2013;98:3341-50. [PMID: 23678033] doi:10.1210/jc.2013-1468 3.
3. Cauley JA, Parimi N, Ensrud KE, Bauer DC, Cawthon PM, Cummings SR, et al; Osteoporotic Fractures in Men (MrOS) Research Group. Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. J Bone Miner Res. 2010;25:545-53. [PMID: 19775201] doi:10.1359/jbmr.090826 4.
4. Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res. 2008;23: 143-50. [PMID: 17907920].
5. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149:242-50. [PMID: 18711154].
6. Cauley JA, Danielson ME, Boudreau R, Barbour KE, Horwitz MJ, Bauer DC, et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: The Women's Health Initiative (WHI). J Bone Miner Res. 2011;26:2378-88. [PMID: 21710614] doi: 10.1002/jbmr.449.
7. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, et al. Vitamin D and Calcium: A Systematic Review of Health Outcomes. Evidence Report/Technology Assessment no. 183. (Prepared by Tufts Evidence-based Practice Center under contract no. 290-2007- 10055-I.) AHRQ publication no. 09-E015. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Accessed at www.ahrq.gov/downloads/pub/evidence/pdf/vitadcal/vitadcal.pdf on 17 January 2014.
8. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007:1-235. [PMID: 18088161].
9. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307-14. [PMID: 20194237] doi:10.7326/0003 -4819-152-5-201003020-00009.
10. Wang L, Song Y, Manson JE, Pilz S, MärzW, Michaëlsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819-29. [PMID: 23149428] doi:10.1161/CIRCOUTCOMES.112.967604.
11. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol. 2012;32:2794-802. [PMID: 22936341] doi:10.1161/ATVBAHA.112 .248039.
12. Sun Q, Pan A, Hu FB, Manson JE, Rexrode KM. 25- Hydroxyvitamin D levels and the risk of stroke: A prospective study and meta-analysis. Stroke. 2012;43:1470-7. [PMID: 22442173] doi: 10.1161/STROKEAHA.111.636910.
13. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol. 2014;2:76- 89. [PMID: 24622671] doi:10.1016/S2213-8587(13)70165-7.
14. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035. [PMID: 24690624] doi:10.1136/bmj.g2035.
15. Yin L, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis of longitudinal studies: serum vitamin D and prostate cancer risk. Cancer Epidemiol. 2009;33:435-45. [PMID: 19939760] doi:10.1016/j .canep.2009.10.014 16.
16. Grant WB. Relation between prediagnostic serum 25- hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B. 2010;101:130-6. [PMID: 20570169] doi:10.1016/j.jphotobiol.2010.04.008.
17. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011;128:1414-24. [PMID: 20473927] doi: 10.1002/ijc.25439 18.
18. Lee JE, Li H, Chan AT, Hollis BW, Lee IM, Stampfer MJ, et al. Circulating levels of vitamin D and colon and rectal cancer: The Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila). 2011;4:735-43. [PMID: 21430073] doi: 10.1158/1940-6207.CAPR-10-0289.
19. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med. 2007;32:210-6. [PMID: 17296473].
20. World Health Organization; International Agency for Research on Cancer. Vitamin D and Cancer. IARC Working Group Reports Volume 5. Lyon, France: International Agency for Research on Cancer; 2008. Accessed at www.iarc.fr/en/publications/pdfs-online/wrk/wrk5/Report-VitD.pdf on 5 November 2014.
21. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007;30:2569-70. [PMID: 17626891].
22. Knekt P, Laaksonen M, Mattila C, Härkänen T, Marniemi J, Heliövaara M, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008;19:666-71. [PMID: 18496468] doi:10.1097/EDE.0b013e318176b8ad.
23. González-Molero I, Rojo-Martínez G, Morcillo S, Gutiérrez- Repiso C, Rubio-Martín E, Almaraz MC, et al. Vitamin D and incidence of diabetes: A prospective cohort study. Clin Nutr. 2012;31: 571-3. [PMID: 22204964] doi:10.1016/j.clnu.2011.12.001 24.
24. Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010;33:2021-3. [PMID: 20805275] doi:10.2337/dc10-0790 25.
25. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care. 2013;36: 1422-8. [PMID: 23613602] doi:10.2337/dc12-0962.
26. Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care. 2013;36: 1361-7. [PMID: 23393216] doi:10.2337/dc12-1050.
27. Schöttker B, Herder C, Rothenbacher D, Perna L, Müller H, Brenner H. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: A competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol. 2013;28:267-75. [PMID: 23354985] doi:10.1007/s10654-013-9769-z 28.
28. Husemoen LL, Skaaby T, Thuesen BH, Jorgensen T, Fenger RV, Linneberg A. Serum 25(OH)D and incident type 2 diabetes: A cohort study. Eur J Clin Nutr. 2012;66:1309-14. [PMID: 23031851] doi: 10.1038/ejcn.2012.134.
29. Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173-82. [PMID: 22526608] doi:10.1007/s00125-012-2544-y.
30. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab. 2010;95: 3225-33. [PMID: 20444911] doi:10.1210/jc.2010-0347.
31. Maddock J, Berry DJ, Geoffroy MC, Power C, Hyppönen E. Vitamin D and common mental disorders in mid-life: cross-sectional and prospective findings. Clin Nutr. 2013;32:758-64. [PMID: 23395104] doi:10.1016/j.clnu.2013.01.006.
32. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014;348:g1903. [PMID: 24690623] doi:10.1136/bmj.g1903.
33. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266- 81. [PMID: 17634462].
34. Fraser WD, Milan AM. Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int. 2013;92:118- 27. [PMID: 23314742] doi:10.1007/s00223-012-9693-3.
35. Institute of Medicine. 2011 Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Pr; 2011.
36. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-30. [PMID: 21646368] doi:10.1210/jc.2011-0385.
37. Holmes EW, Garbincius J, McKenna KM. Analytical variability among methods for the measurement of 25-hydroxyvitamin D: still adding to the noise. Am J Clin Pathol. 2013;140:550-60. [PMID: 24045553] doi:10.1309/AJCPU2SKW1TFKSWY.
38. Lai JK, Lucas RM, Banks E, Ponsonby AL; Ausimmune Investigator Group. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J. 2012;42:43-50. [PMID: 21395958] doi:10.1111/j.1445-5994.2011.02471.x.
39. Bedner M, Lippa KA, Tai SS. An assessment of 25-hydroxyvitamin D measurements in comparability studies conducted by the Vitamin D Metabolites Quality Assurance Program. Clin Chim Acta. 2013; 426:6-11. [PMID: 23978484] doi:10.1016/j.cca.2013.08.012.
40. Cashman KD, Kiely M, Kinsella M, Durazo-Arvizu RA, Tian L, Zhang Y, et al. Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: A case study of the program's potential for national nutrition and health surveys. Am J Clin Nutr. 2013;97:1235-42. [PMID: 23615829] doi: 10.3945/ajcn.112.057182.
41. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem. 2009;42:1549-56. [PMID: 19631201] doi:10.1016/j .clinbiochem.2009.07.013 42.
42. Binkley N, Krueger DC, Morgan S, Wiebe D. Current status of clinical 25-hydroxyvitamin D measurement: An assessment of between-laboratory agreement. Clin Chim Acta. 2010;411:1976-82. [PMID: 20713030] doi:10.1016/j.cca.2010.08.018 43.
43. Moon HW, Cho JH, Hur M, Song J, Oh GY, Park CM, et al. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem. 2012;45:326-30. [PMID: 22244986] doi:10.1016/j.clinbiochem.2011 .12.025.
44. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets. 2011;12:19-28. [PMID: 20795940].
45. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-8. [PMID: 21118827] doi:10.1210/jc.2010-2704.
46. LeBlanc E, Chou R, Zakher B, Daeges M, Pappas M. Screening for Vitamin D Deficiency: Systematic Review for the U.S. Preventive Servies Task Force Recommendation [in press]. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
47. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief. 2011:1-8. [PMID: 21592422].
48. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988- 2004. Arch Intern Med. 2009;169:626-32. [PMID: 19307527] doi: 10.1001/archinternmed.2008.604.
49. McCullough ML, Weinstein SJ, Freedman DM, Helzlsouer K, Flanders WD, Koenig K, et al. Correlates of circulating 25- hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172:21-35. [PMID: 20562191] doi:10.1093/aje/kwq113.
50. Orwoll E, Nielson CM, Marshall LM, Lambert L, Holton KF, Hoffman AR, et al; Osteoporotic Fractures in Men (MrOS) Study Group. Vitamin D deficiency in older men. J Clin Endocrinol Metab. 2009; 94:1214-22. [PMID: 19174492] doi:10.1210/jc.2008-1784.
51. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31:48-54. [PMID: 21310306] doi:10.1016/j.nutres.2010.12.001.
52. Jacques PF, Felson DT, Tucker KL, Mahnken B, Wilson PW, Rosenberg IH, et al. Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr. 1997;66:929- 36. [PMID: 9322570].
53. Millen AE, Wactawski-Wende J, Pettinger M, Melamed ML, Tylavsky FA, Liu S, et al. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: The Women's Health Initiative calcium plus vitamin D clinical trial. Am J Clin Nutr. 2010; 91:1324-35. [PMID: 20219959] doi:10.3945/ajcn.2009.28908.
54. Linos E, Keiser E, Kanzler M, Sainani KL, Lee W, Vittinghoff E, et al. Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006. Cancer Causes Control. 2012;23:133- 40. [PMID: 22045154] doi:10.1007/s10552-011-9862-0.
55. Samuel L, Borrell LN. The effect of body mass index on optimal vitamin D status in U.S. adults: The National Health and Nutrition Examination Survey 2001-2006. Ann Epidemiol. 2013;23:409-14. [PMID: 23790345] doi:10.1016/j.annepidem.2013.05.011.
56. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70, 528 patients from eight major vitamin D trials. J Clin Endocrinol Metab. 2012;97:2670-81. [PMID: 22605432] doi: 10.1210/jc.2011-3328.
57. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 2010; 340:b5463. [PMID: 20068257] doi:10.1136/bmj.b5463.
58. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88:582S-586S. [PMID: 18689406].
59. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-56. [PMID: 10232622].
60. Moyer VA; U.S. Preventive Services Task Force. Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157: 197-204. [PMID: 22868837].
61. U.S. Preventive Services Task Force. Vitamin D and Calcium Supplementation to Prevent Cancer and Osteoporotic Fractures in Adults: Draft Recommendation Statement. Rockville, MD: U.S. Preventive Services Task Force; 2014.
62. U.S. Preventive Services Task Force. Final Recommendation Statement: Vitamin D and Calcium to Prevent Fractures: Preventive Medication. Rockville, MD: U.S. Preventive Services Task Force; 2014. Accessed at www.uspreventiveservicestaskforce.org/uspstf12/vitamind/finalrecvitd.htm on 17 January 2014.
63. U.S. Preventive Services Task Force. Final Recommendation Statement: Vitamin Supplementation to Prevent Cancer and CVD: Counseling. Rockville, MD: U.S. Preventive Services Task Force; 2014. Accessed at www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling on 5 November 2014.
64. Jackson RD, LaCroix AZ, Cauley JA, McGowan J. The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13:S98-106. [PMID: 14575942].
65. U.S. Preventive Services Task Force. Procedure Manual. AHRQ publication no. 08-05118-EF. December 2013. Accessed at www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm on 3 April 2013.
66. Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Stat Med. 1996;15:619-29. [PMID: 8731004].
67. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. [PMID: 12958120].
68. Brazier M, Grados F, Kamel S, Mathieu M, Morel A, Maamer M, et al. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, doubleblind, placebo-controlled study. Clin Ther. 2005;27:1885-93. [PMID: 16507374].
69. Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The Decalyos II study. Osteoporos Int. 2002;13:257-64. [PMID: 11991447].
70. Gallagher JC, Peacock M, Yalamanchili V, Smith LM. Effects of vitamin D supplementation in older African American women. J Clin Endocrinol Metab. 2013;98:1137-46. [PMID: 23386641] doi:10.1210/jc.2012-3106 71.
71. Gallagher JC, Jindal PS, Smith LM. Vitamin D supplementation in young White and African American women. J Bone Miner Res. 2014; 29:173-81. [PMID: 23761326] doi:10.1002/jbmr.2010.
72. Grimnes G, Figenschau Y, Almas B, Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes. 2011;60:2748-57. [PMID: 21911741] doi:10.2337/db11 -0650.
73. Lips P, Binkley N, Pfeifer M, Recker R, Samanta S, Cohn DA, et al. Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr. 2010;91:985-91. [PMID: 20130093] doi:10.3945/ajcn.2009.28113.
74. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000;15:1113-8. [PMID: 10841179].
75. Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, et al. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: A randomized controlled trial. Endocr Pract. 2009;15:203-12. [PMID: 19364687].
76. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M, Salis C, et al. Effects of vitamin D and calcium supplementation on falls: A randomized controlled trial. J Bone Miner Res. 2003;18:343-51. [PMID: 12568412].
77. Kärkkäinen M, Tuppurainen M, Salovaara K, Sandini L, Rikkonen T, Sirola J, et al. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: A 3-year randomized population-based trial (OSTPRE-FPS). Osteoporos Int. 2010;21: 2047-55. [PMID: 20204604] doi:10.1007/s00198-009-1167-8 78.
78. Kärkkäinen MK, Tuppurainen M, Salovaara K, Sandini L, Rikkonen T, Sirola J, et al. Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65-71 years? A 3-year randomized population-based trial (OSTPRE-FPS). Maturitas. 2010;65:359-65. [PMID: 20060665] doi:10.1016/j.maturitas.2009.12.018.
79. Kjargaard M, Waterloo K, Wang CE, Almas B, Figenschau Y, Hutchinson MS, et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry. 2012;201:360-8. [PMID: 22790678] doi:10.1192/bjp.bp.111 .104349.
80. Krieg MA, Jacquet AF, Bremgartner M, Cuttelod S, Thiébaud D, Burckhardt P. Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: A longitudinal study. Osteoporos Int. 1999;9:483-8. [PMID: 10624454].
81. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1996;124:400-6. [PMID: 8554248].
82. Gallagher JC, Sai A, Templin T 2nd, Smith L. Dose response to vitamin D supplementation in postmenopausal women: A randomized trial. Ann Intern Med. 2012;156:425-37. [PMID: 22431675] doi: 10.7326/0003-4819-156-6-201203200-00005.
83. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab. 1995;80:1052-8. [PMID: 7714065].
84. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner- Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2009;20:315- 22. [PMID: 18629569] doi:10.1007/s00198-008-0662-7.
85. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: A parallel-group, double-blind, placebocontrolled RCT. J Clin Endocrinol Metab. 2012;97:3557-68. [PMID: 22865902] doi:10.1210/jc.2012-2126.
86. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, et al; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008;100:1581-91. [PMID: 19001601] doi:10.1093/jnci/djn360.
87. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, et al; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008;31:701-7. [PMID: 18235052] doi:10.2337/dc07-1829.
88. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669-83. [PMID: 16481635].
89. LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: The Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009;64:559-67. [PMID: 19221190] doi:10.1093/gerona/glp006.
90. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-96. [PMID: 16481636].
91. Williams DA, Arnold LM. Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S86-97. [PMID: 22588773] doi:10.1002/acr.20531.
92. Aloia JF, Patel M, Dimaano R, Li-Ng M, Talwar SA, Mikhail M, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008;87:1952-8. [PMID: 18541590].
93. Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med. 2005;165:1618-23. [PMID: 16043680].
94. Harris SS, Dawson-Hughes B, Perrone GA. Plasma 25- hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. J Am Coll Nutr. 1999;18:470-4. [PMID: 10511329].
95. Talwar SA, Aloia JF, Pollack S, Yeh JK. Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 2007;86:1657-62. [PMID: 18065583].
96. Berlin T, Emtestam L, Björkhem I. Studies on the relationship between vitamin D3 status and urinary excretion of calcium in healthy subjects: effects of increased levels of 25-hydroxyvitamin D3. Scand J Clin Lab Invest. 1986;46:723-9. [PMID: 3026026].
97. Honkanen R, Alhava E, Parviainen M, Talasniemi S, Mönkkönen R. The necessity and safety of calcium and vitamin D in the elderly. J Am Geriatr Soc. 1990;38:862-6. [PMID: 2387950].
98. Janssen HC, Samson MM, Verhaar HJ. Muscle strength and mobility in vitamin D-insufficient female geriatric patients: A randomized controlled trial on vitamin D and calcium supplementation. Aging Clin Exp Res. 2010;22:78-84. [PMID: 20305368].
99. Lehmann U, Hirche F, Stangl GI, Hinz K, Westphal S, Dierkes J. Bioavailability of vitamin D(2) and D(3) in healthy volunteers, a randomized placebo-controlled trial. J Clin Endocrinol Metab. 2013;98: 4339-45. [PMID: 24001747] doi:10.1210/jc.2012-4287.
100. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007;176:208-13. [PMID: 17463418].
101. Wamberg L, Kampmann U, Stodkilde-Jorgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels-results from a randomized trial. Eur J Intern Med. 2013;24:644-9. [PMID: 23566943] doi:10 .1016/j.ejim.2013.03.005.
102. Wamberg L, Pedersen SB, Richelsen B, Rejnmark L. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study. Calcif Tissue Int. 2013;93:69-77. [PMID: 23591713] doi:10 .1007/s00223-013-9729-3.
103. Knutsen KV, Madar AA, Lagerlov P, Brekke M, Raastad T, Stene LC, et al. Does vitamin D improve muscle strength in adults? A randomized, double-blind, placebo-controlled trial among ethnic minorities in Norway. J Clin Endocrinol Metab. 2014;99:194-202. [PMID: 24248184] doi:10.1210/jc.2013-2647.
104. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: An updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:827-38. [PMID: 22184690] doi:10.7326/0003-4819-155-12-201112200-00005.
105. Michael YL, Whitlock EP, Lin JS, Fu R, O'Connor EA, Gold R; US Preventive Services Task Force. Primary care-relevant interventions to prevent falling in older adults: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2010;153:815-25. [PMID: 21173416] doi:10.7326/0003-4819-153-12 -201012210-00008.
106. Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013; 159:824-34. [PMID: 24217421].
107. Cornell JE, Mulrow CD, Localio R, Stack CB, Meibohm AR, Guallar E, et al. Random-effects meta-analysis of inconsistent effects: A time for change. Ann Intern Med. 2014;160:267-70. [PMID: 24727843].
108. Ott SM, Chesnut CH 3rd. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med. 1989;110:267-74. [PMID: 2913914].
109. Orwoll ES, McClung MR, Oviatt SK, Recker RR, Weigel RM. Histomorphometric effects of calcium or calcium plus 25- hydroxyvitamin D3 therapy in senile osteoporosis. J Bone Miner Res. 1989;4:81-8. [PMID: 2718782].
110. Mastaglia SR, Mautalen CA, Parisi MS, Oliveri B. Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur J Clin Nutr. 2006;60:681-7. [PMID: 16391587].
111. Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stähelin HB, Willett WC, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: A randomized controlled trial. Arch Intern Med. 2010;170:813-20. [PMID: 20458090] doi:10.1001/archinternmed.2010.67.
112. Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly highrisk women. Arch Intern Med. 2008;168:103-8. [PMID: 18195202] doi:10.1001/archinternmed.2007.31.
113. Zhu K, Bruce D, Austin N, Devine A, Ebeling PR, Prince RL. Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res. 2008;23: 1343-8. [PMID: 18410225] doi:10.1359/jbmr.080327.
114. Latham NK, Anderson CS, Lee A, Bennett DA, Moseley A, Cameron ID; Fitness Collaborative Group. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: The Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc. 2003;51:291-9. [PMID: 12588571].
115. Gloth FM 3rd, Smith CE, Hollis BW, Tobin JD. Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. J Am Geriatr Soc. 1995;43:1269-71. [PMID: 7594162].
116. Corless D, Dawson E, Fraser F, Ellis M, Evans SJ, Perry JD, et al. Do vitamin D supplements improve the physical capabilities of elderly hospital patients?AgeAgeing. 1985;14:76-84. [PMID: 4003187].
117. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013;36:260-6. [PMID: 23033239] doi: 10.2337/dc12-1204.
118. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: A randomized controlled trial. Circ Heart Fail. 2010;3:195-201. [PMID: 20103775] doi:10.1161/CIRCHEARTFAILURE.109.907899.
119. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754-9. [PMID: 16600924].
120. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet. 2011;377:242-50. [PMID: 21215445] doi:10.1016/S0140-6736(10)61889-2.
121. Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol. 2006;92:26-32. [PMID: 16766239].
122. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. Accessed at http://nof.org/files/nof/public/content/file/344/upload/159.pdf on 5 November 2014.
123. Dawson-Hughes B, Cooper C; International Osteoporosis Foundation. IOF statement of new IOM dietary reference intakes for calcium and vitamin D. Accessed at www.iofbonehealth.org/iof-statement-new-iom-dietary-reference-intakes-calcium-and-vitamin-d on 5 November 2014.
124. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21:1151-4. [PMID: 20422154] doi:10.1007/s00198-010-1285-3.